The DOX-induced MAPK activation and cell death were enhanced when DOX was co-administered with CB1agonists AEA or HU210 significantly
The DOX-induced MAPK activation and cell death were enhanced when DOX was co-administered with CB1agonists AEA or HU210 significantly. and…